Simple Summary Treatment strategies for early breast cancer have significantly improved in
the last decades. Several new effective agents have proved clinical benefit and have …

Invasive breast cancer is generally treated with some form of systemic “adjuvant” therapy,
including combinations of cytotoxic chemotherapy, HER2 targeted therapy, immunotherapy …

Purpose The purpose of the study was to assess the utility of tumor biomarkers, ultrasound
(US) and US-guided diffuse optical tomography (DOT) in early prediction of breast cancer …

Stemness and epithelial–mesenchymal plasticity are widely studied in the circulating tumor
cells of breast cancer patients because the roles of both processes in tumor progression are …

Background This study created a predictive preoperative nomogram dependent on
multimodal ultrasound characteristics and primary lesion biopsy results for various …

Background Few studies have focused on converting ER-low-positive and HER2-low status
following neoadjuvant therapy (NAT). We aimed to assess the evolution in ER and HER2 …

Purpose The survival benefits of neoadjuvant chemotherapy (NAC) for locally advanced
gastric cancer (LAGC) patients are inconsistent. This study aims to investigate how different …

Secreted protein acidic and rich in cysteine (SPARC) expression has been proposed as a
prognostic and predictive biomarker for some cancer types, but knowledge about the …

Simple Summary Circulating tumor DNA (ctDNA) is increasingly employed in the
management of malignant diseases, though the implementation of ctDNA diagnostics in …

PURPOSE Neoadjuvant chemotherapy (NAC) is increasingly used in breast cancer.
Predictive modeling is useful in predicting pathologic complete response (pCR) to NAC. We …